Yue, X.; Stauff, E.; Boyapati, S.; Langhans, S.A.; Xu, W.; Makrogiannis, S.; Okorie, U.J.; Okorie, A.M.; Kandula, V.V.R.; Kecskemethy, H.H.;
et al. PET Imaging of Neurofibromatosis Type 1 with a Fluorine-18 Labeled Tryptophan Radiotracer. Pharmaceuticals 2024, 17, 685.
https://doi.org/10.3390/ph17060685
AMA Style
Yue X, Stauff E, Boyapati S, Langhans SA, Xu W, Makrogiannis S, Okorie UJ, Okorie AM, Kandula VVR, Kecskemethy HH,
et al. PET Imaging of Neurofibromatosis Type 1 with a Fluorine-18 Labeled Tryptophan Radiotracer. Pharmaceuticals. 2024; 17(6):685.
https://doi.org/10.3390/ph17060685
Chicago/Turabian Style
Yue, Xuyi, Erik Stauff, Shriya Boyapati, Sigrid A. Langhans, Wenqi Xu, Sokratis Makrogiannis, Uchenna J. Okorie, Azubuike M. Okorie, Vinay V. R. Kandula, Heidi H. Kecskemethy,
and et al. 2024. "PET Imaging of Neurofibromatosis Type 1 with a Fluorine-18 Labeled Tryptophan Radiotracer" Pharmaceuticals 17, no. 6: 685.
https://doi.org/10.3390/ph17060685
APA Style
Yue, X., Stauff, E., Boyapati, S., Langhans, S. A., Xu, W., Makrogiannis, S., Okorie, U. J., Okorie, A. M., Kandula, V. V. R., Kecskemethy, H. H., Nikam, R. M., Averill, L. W., & Shaffer, T. H.
(2024). PET Imaging of Neurofibromatosis Type 1 with a Fluorine-18 Labeled Tryptophan Radiotracer. Pharmaceuticals, 17(6), 685.
https://doi.org/10.3390/ph17060685
